These results were ascribed to TRAIL contribution to the negative selection of autoreactive thymocytes—which could account also for its anticancer activity—[10], and suggested that TRAIL could be an important immune regulator, opposing T1DM development. The gene discussed is TNFSF10; the disease is type 1 diabetes mellitus.